Matt is a seasoned CFO known for driving growth at both clinical and commercial stage biopharmaceutical organizations via strategic financial and business development efforts. Matt most recently served as Chief Financial Officer of Kalaris Therapeutics. Prior to that, he acted as Chief Financial Officer of iTeos Therapeutics. He also previously held roles of positions of increasing responsibility at Sarepta Therapeutics, Celgene Corporation, and Gilead Sciences across the finance and business development functions.

Matt has a Bachelor of Science in Business Administration from Bowling Green State University and a Master of Business Administration from The University of Chicago.